TheJobsMapBridgeBio Oncology Therapeutics (BBOT) jobs and careers
South San Francisco, United States
About BridgeBio Oncology Therapeutics (BBOT)
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next generation pipeline of novel small molecule therapeutics targeting RAS and PI3K malignancies. Initially formed as a subsidiary of BridgeBio, BridgeBio Oncology Therapeutics completed a $200M private financing with external investors in 2024 with the goal of improving outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors.
- Founded
- 2014
- Employees
- 11 to 50
- Total funding
- $200M
- Headquarters
- South San Francisco
Leadership
The top of BridgeBio Oncology Therapeutics (BBOT)'s org chart, with how many people report into each leader.
Eli Wallace
Chief Executive Officer
64 reports
Pedro J. Beltran
Chief Scientific Officer
30 reports
Idan E.
Senior Vice President, Strategy & Business Development
10 reports
Uneek Mehra
Chief Financial Officer
7 reports
Howard Chang
Vice President, Operations
6 reports
Angela Peters
SVP People
2 reports
Aaron Chan
VP Head Of Legal
1 report
Christine Z. Yang
Chief Of Staff
1 report
Jobs at BridgeBio Oncology Therapeutics (BBOT)
No open positions right now. Explore more companies on TheJobsMap.